+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Sterile Tubing Welder Market Outlook 2028

  • PDF Icon

    Report

  • 75 Pages
  • May 2021
  • Region: North America
  • Research Nester Pvt. Ltd
  • ID: 5336073
Sterile tube welders are primarily being used to weld the sterile tubes in healthcare settings, biotech labs., diagnostic centers, blood banks and research institutions. The North America sterile tubing welders market is anticipated to grow with a CAGR of 4.40% during the forecast period, i.e., 2020-2028. Factors such as the rising prevalence of chronic diseases and blood disorders, along with the increasing focus of the government of nations worldwide to improve their existing medical infrastructure by increasing their expenditure on healthcare, and the rising demand for sterile tubes in the end-user industries are anticipated to drive the market growth in the coming years. The market is anticipated to attain a revenue of close to USD 1500 Million in 2028 from a value of about USD 1100 Million in 2019. Additionally, factors such as the increasing awareness for blood transfusions and blood awareness in North America is also anticipated to drive the market growth.

The North America sterile tubing welders market is segmented on the basis of connection type into dry-dry connections, wet-dry connections, wet-wet connections, and multiple use. Out of these, the wet-dry connections segment is anticipated to register the largest market share in the year 2021 and grow with the highest CAGR of close to 5% during the forecast period. The market is also segmented on the basis of mode into automatic and manual, out of which, the automatic segment is anticipated to grow with a CAGR of close to 4% during the forecast period.

Some of the key players in the North America sterile tubing welders market are Terumo BCT, Inc., Sartorius AG, GenesisBPS, MGA Technologies, Cytiva (Global Life Sciences Solutions USA LLC), Vante Biopharm/Sebra, Pall Corporation, Saint-Gobain Performance Plastics, and others.

Table of Contents

North America Sterile Tubing Welders Market
1. Introduction
1.1. Market Definition
1.2. Market Segmentation
1.3. Product overview
2. Research Methodology
2.1. Research process
2.2. Primary research
2.2.1. Sterile Tubing Welders Manufacturers
2.2.2. Distributors
2.2.3. End-users
2.3. Secondary research
2.4. Market size estimation
3. Executive Summary- North America Sterile Tubing Welders Market
4. Analysis of Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
4.4. Trends
5. Regulatory & Standards Landscape6. Pricing Analysis
7. Impact of COVID-19 on the Sterile Tubing Welders Market
7.1. Impact on the overall market
7.2. Impact on the manufacturing
7.3. Impact on the supply & distribution
7.4. Impact on the key market players
7.5. Impact on overall price trend
7.6. Market impact analysis in 2020 (quarter wise) w.r.t covid-19 pandemic (USD Millions)
8. Competitive Structure
8.1. Terumo BCT, Inc.
8.2. Sartorius AG
8.3. GenesisBPS
8.4. MGA Technologies
8.5. Cytiva (Global Life Sciences Solutions USA LLC)
8.6. Vante Biopharm/Sebra
8.7. Pall Corporation
8.8. Saint-Gobain Performance Plastics
9. North America Sterile Tubing Welders Market Outlook
9.1. By value (USD Million)
10. North America Sterile Tubing Welders Market Segmentation Analysis 2019-2028
10.1. By mode
10.1.1. Automatic, 2019-2028F (USD Million)
10.1.2. Manual, 2019-2028F (USD Million)
10.2. By connection type
10.2.1. Dry-dry connections, 2019-2028F (USD Million)
10.2.2. Wet-dry connections, 2019-2028F (USD Million)
10.2.3. Wet-wet connections, 2019-2028F (USD Million)
10.3. By end-user & application
10.3.1. Hospitals, 2019-2028F (USD Million)
10.3.1.1. Component pooling, 2019-2028F (USD Million)
10.3.1.2. Quality control sampling, 2019-2028F (USD Million)
10.3.1.3. Leukoreduction, 2019-2028F (USD Million)
10.3.1.4. Fluid replacement, 2019-2028F (USD Million)
10.3.1.5. Pathogen reduction, 2019-2028F (USD Million)
10.3.1.6. Cell washing & freezing, 2019-2028F (USD Million)
10.3.1.7. Others, 2019-2028F (USD Million)
10.3.2. Biotechnology & pharmaceutical companies, 2019-2028F (USD Million)
10.3.2.1. Component pooling, 2019-2028F (USD Million)
10.3.2.2. Quality control sampling, 2019-2028F (USD Million)
10.3.2.3. Leukoreduction, 2019-2028F (USD Million)
10.3.2.4. Fluid replacement, 2019-2028F (USD Million)
10.3.2.5. Pathogen reduction, 2019-2028F (USD Million)
10.3.2.6. Cell washing & freezing, 2019-2028F (USD Million)
10.3.2.7. Others, 2019-2028F (USD Million)
10.3.3. Diagnostic laboratories, 2019-2028F (USD Million)
10.3.3.1. Component pooling, 2019-2028F (USD Million)
10.3.3.2. Quality control sampling, 2019-2028F (USD Million)
10.3.3.3. Leukoreduction, 2019-2028F (USD Million)
10.3.3.4. Fluid replacement, 2019-2028F (USD Million)
10.3.3.5. Pathogen reduction, 2019-2028F (USD Million)
10.3.3.6. Cell washing & freezing, 2019-2028F (USD Million)
10.3.3.7. Others, 2019-2028F (USD Million)
10.3.4. Blood banks, 2019-2028F (USD Million)
10.3.4.1. Component pooling, 2019-2028F (USD Million)
10.3.4.2. Quality control sampling, 2019-2028F (USD Million)
10.3.4.3. Leukoreduction, 2019-2028F (USD Million)
10.3.4.4. Fluid replacement, 2019-2028F (USD Million)
10.3.4.5. Pathogen reduction, 2019-2028F (USD Million)
10.3.4.6. Cell washing & freezing, 2019-2028F (USD Million)
10.3.4.7. Others, 2019-2028F (USD Million)
10.3.5. Research organizations, 2019-2028F (USD Million)
10.3.5.1. Component pooling, 2019-2028F (USD Million)
10.3.5.2. Quality control sampling, 2019-2028F (USD Million)
10.3.5.3. Leukoreduction, 2019-2028F (USD Million)
10.3.5.4. Fluid replacement, 2019-2028F (USD Million)
10.3.5.5. Pathogen reduction, 2019-2028F (USD Million)
10.3.5.6. Cell washing & freezing, 2019-2028F (USD Million)
10.3.5.7. Others, 2019-2028F (USD Million)

Companies Mentioned

  • Terumo BCT Inc.
  • Sartorius AG
  • GenesisBPS
  • MGA Technologies
  • Cytiva (Global Life Sciences Solutions USA LLC)
  • Vante Biopharm/Sebra
  • Pall Corporation
  • Saint-Gobain Performance Plastics